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Abstract 
 
Introduction: Elevated circulating non-esterified fatty acids including oleic acid (OA) are 
associated with many pregnancy related complications. Prostaglandins (PGs) play crucial roles 
during parturition. We investigated the effect of OA supplementation on PG production using 
an in vitro model of ovine placenta.  
 
Methods: Maternal endometrium (ME) and fetal allantochorion (FC) were collected in late 
pregnancy (day 135). Confluent cells were cultured in serum-free medium supplemented with 
0, 20 or 100 µM OA and challenged with control medium, oxytocin (OT, 250 nM), 
lipopolysaccharide (LPS, 0.1 µg/ml) or dexamethasone (DEX, 5 µM). Spent medium was 
harvested at 2 and 24 h after challenge for quantifying PGs. 
 
Results: In ME cells OA increased PGE2 production moderately but attenuated PGF2α 
production leading to a doubling of the PGE2:PGF2α ratio (E:F) (P<0.01). Without OA, both 
OT and LPS stimulated PG production about 3-fold (P<0.01) without changing the E:F ratio. 
In the ME cells challenged with OT, OA decreased both PGE2 and PGF2α production by up to 
70% (P<0.01) whereas in LPS treated cells OA increased the E:F ratio. In FC cells PGE2 
production at 2 h was stimulated by 100 µM OA (P<0.05). In these cells LPS caused a 3-fold 
increase in PGE2 (P<0.01), an effect which was completely inhibited by DEX. 
 
Discussion: OA supplementation favours basal PGE2 production in both ME and FC. In ME 
OA increased E:F ratios and antagonized the stimulatory effect of OT on PG production. This 
suggests that raised circulating OA may affect both the initiation and progression of parturition. 
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Introduction  
 
Maternal obesity now affects around 20% of pregnancies in many westernised countries [1]. 
Obesity increases the risk of many pregnancy related complications including pre-eclampsia 
[2], pre-term birth [3], prolonged labour [4] and emergency caesarean section [5]. Obesity is 
associated with aberrant lipid metabolism and higher circulating concentrations of free fatty 
acids [6, 7]. Women with non-esterified fatty acids (NEFA) levels in the highest tertile were at 
about twice the risk of spontaneous pre-term birth than those in the lowest tertile [3]. Amongst 
these, oleic acid (OA, 18:1n-9) accounts for about 30% of the NEFAs circulating during 
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pregnancy in women and up to 45% in sheep [8]: its concentration increases in women with 
gestational diabetes mellitus [9] and OA was the NEFA with the greatest increase (67%) 
associated with pre-eclampsia [6]. OA also constituted around 10% of the fatty acids present 
in amniotic fluid [10] and 30% of total membrane fatty acids in immortalised pregnant human 
myometrial cells [11]. Circulating NEFA concentrations including OA also rise during 
negative energy balance when body lipids are mobilised to supply extra energy [7]. In addition, 
OA is a principal effective ingredient within foodstuffs such as olive oil and peanuts which are 
believed to have positive effects on human health, such as protection from cardiovascular 
disease [12, 13]. Both in vivo and in vitro studies have shown that OA can reduce the negative 
metabolic effects of elevated dietary saturated fatty acids [14].  
 
In mammals, various eicosanoids including prostaglandins (PGs) and leukotrienes are 
produced by the metabolism of n-3 and n-6 polyunsaturated fatty acids (PUFAs).  The key 
enzymes in these metabolic pathways, Δ6, Δ5 desaturase and prostaglandin-endoperoxide 
synthase (PTGS), are rate limiting to a large number of substrates, including 18 and 22 carbon 
fatty acids [15]. Therefore, OA supplementation may alter metabolism of PUFA and the PG 
synthetic pathways through enzyme competition. Unsaturated fatty acids (UFAs) are important 
signalling molecules controlling many cellular processes [16] so OA may compete with PUFAs 
for incorporation into phospholipid membranes and reduce availability of the PG precursors. 
Such evidence was found in a study showing that unsaturated fatty acids, including OA, 
inhibited induced activation of NFkB and PTGS2 expression mediated through toll-like 4 
receptors [16]; [17].  
 
PGs, especially the 2-series, are key signalling molecules in reproductive processes including 
ovulation, luteolysis, menstruation and parturition [18, 19]. Parturition in the ewe is initiated 
by activation of the fetal hypothalamic-pituitary-adrenal axis, followed by a concurrent 
increase in plasma cortisol and oestradiol production,  that up-regulates PTGS2 expression and 
down-regulates PG dehydrogenase (PGDH), resulting in increased PG synthesis [20]. In the 
late pregnant ewe, PGE2 is produced primarily by the fetal component of the placentome, and 
concentrations rise over the last 3 weeks of gestation to aid fetal maturation [21]. At term, PGE2 
causes cervical dilatation whereas PGF2α is released through oxytocin (OT) binding to its 
receptors in the intercotyledonary endometrium and stimulates uterine contractions and 
delivery [20, 22, 23]. Synthetic glucocorticoids, such as dexamethesone (DEX) mimic the 
endogenous cortisol rise and induce parturition and pre-term birth [20]. Intrauterine infection 
is another major risk factor for preterm labour [24]. The bacterial endotoxin lipopolysaccharide 
(LPS) increases the activities of phospholipase (PL)A2 and PTGS2, and inhibits PGDH [25, 
26]. LPS induces NFkB activation which is a key signalling pathway in infection-induced 
preterm labour [27]. 
 
The aim of the present study was, therefore, to test the hypothesis that supplementing maternal 
endometrial (ME) and fetal allantochorion (FC) cells isolated from late gestation ewes with 
different concentrations of OA would: (i) influence PG production and (ii) alter their response 
to the agonists OT, LPS and DEX.  
 
Materials and methods 
 
All reagents were from Sigma (Sigma-Aldrich Company Ltd, Poole, Dorset, UK) or BDH 
Merck Ltd (Lutterworth, Leics, UK) unless otherwise stated. Solutions were sterilised by 
passage through a 0.20 µm filter (Nalge Nunc International, Rochester, NY14602-0365, USA 
or Millipore Company, Bedford, MA01730, USA). All culture media used included 50,000 
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units/L penicillin and 50 mg/L streptomycin. All animal experiments were carried out under 
the Animal (Scientific Procedures, UK) Act 1986. 
 
Animals, cell isolation and culture 
 
Tissues for the study were obtained post mortem from 9 ewes on Day 135 of gestation (term is 
approximately 145 days). ME and FC cells were separated and cultured following the methods 
described previously [28]. The FC cells were taken from the intercotyledonary regions of the 
placenta to avoid possible contamination with maternal tissue. 
  
OA supplementation and cell challenge 
 
OA (cis-9-Octadecenoic acid, Sigma) was dissolved in 100% ethanol to a concentration of 100 
mM. It was diluted further to 10 mM in the dilution medium (serum free DMEM/F12 medium 
containing 0.1125 % BSA as a carrier). OT (Sigma) was dissolved in 0.01 M acetic acid at a 
concentration of 5 mM. Further dilution to 500 M was made in the dilution medium. LPS 
from E. Coli 026.B6 (Sigma) was dissolved in distilled water at 500 g/ml then diluted to 50 
g/ml in dilution medium. DEX (Sigma) was dissolved in 100 % ethanol to 20 mM, then 
diluted to 2 mM in the dilution medium. The solutions were sterilised by passing through a 
0.20 m filter (Nalge Nunc International, Rochester, NY14602-0365, USA).  
 
The isolated endometrial cells were cultured in DMEM/F12 medium containing 10% fetal calf 
serum (FCS) and culture medium was changed every 48 h for 7–8 days to allow the cells to 
grow to confluence as checked using microscopy. Prior to the OA supplementation, the FCS 
present in the confluent cells was removed via incubation with 2 ml serum-free test medium 
(DMEM/F12 medium containing 0.1125 % BSA, 50,000 units/L penicillin and streptomycin, 
and 1 ml/L ITS (0.5 mg/ml insulin, 0.5 mg/ml transferin and 0.5 g/ml selenium; Sigma) for 3 
h. The cells were then cultured in 2 ml test medium containing 0 (CONT), 20 or 100 µM OA 
for 45 h. After this, the cells were incubated for a further 2 h or 24 h with either: (i) control 
medium (CM); (ii) 250 nM OT (endometrial cells only), (iii) 0.1 g/ml LPS, (iv) 5 μM DEX 
or (v) 0.1 μg/ml LPS + 5 μM DEX in 1 ml of the above OA supplemented medium.  Spent 
medium was collected and stored at -20C until analysis. There were four replicate wells per 
treatment for each ewe and all treatments were repeated in cells isolated from at least 3 separate 
ewes. The doses of OA and challenge were selected to fall within the effective range following 
preliminary work using a wider dose response curve. The maximum ethanol concentration in 
the incubation medium was less than 0.05%. 
 
PG radioimmunoassay (RIA) 
 
PGE2 and PGF2 in the spent medium were quantified using charcoal-dextran coated RIA 
methods as described previously [29]. The samples were diluted (10-200) in the RIA buffer. 
This allowed the measured PG concentrations to fall within the effective analytical area of the 
standard curves and minimized the effect of medium on the RIA to a negligible level, making 
extraction unnecessary. The PG antisera were a kind gift from Dr N L Poyser (University of 
Edinburgh, Edinburgh, UK). Their cross-reactivities were as follows: PGF2 antiserum, 34% 
with PGF1 and 25% with PGF3; PGE2 antiserum, 23% with PGE1 and 15% with PGE3. The 
limit of detection was 2 pg/tube for PGE2 and 1 pg/tube for PGF2.The limit of detection was 
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2 pg/tube for PGE2 and 1 pg/tube for PGF2α. The intra-assay and inter-assay coefficients of 
variation were 3.5% and 6.3% for PGE2 (n = 6), and 4.1% and 9.6% for PGF2α, respectively (n 
= 6). 
 
Statistical analysis 
 
The data are expressed as mean  standard error (S.E.) unless otherwise stated. Data analysis 
was carried out using an SPSS V22 software package (SPSS Inc, Chicago, IL, USA). The data 
were checked for distribution using a Levene’s test of equality of error variance. Where 
necessary, logarithmic transformation was carried out to achieve homogeneity. Analysis of 
variance (ANOVA) with repeated measurement was carried out via a linear mixed effect model, 
which took the differences between treatments, time, challenges and their interactions as the 
fixed effects and ewe as the random effect. Where a significant difference (P<0.05) was 
achieved, the least square means based on Fisher’s LSD for multiple comparisons were 
calculated to examine the differences between the above fixed effects.  
 
Results 
 
Effect of challenge on PG production by ME cells 
 
The effects of challenge with CONT, OT, LPS or DEX in the ME cells without OA 
supplementation are shown in Fig. 1. OT challenge stimulated both PGE2 and PGF2α 
generation at 2 h and 24 h. LPS increased PGE2 and PGF2α production at 24 h only, but to a 
lesser extent than OT and statistical significance was only achieved for PGF2α compared with 
the cells without challenge. DEX did not alter PG production in most of the treatment groups 
except that it decreased the PGF2α concentration at 24 h. OT and LPS did not change the ratios 
of PGE2 to PGF2α (E:F) while DEX increased those ratios at both 2 h and 24 h. 
 
Effect of OA supplementation on PG production by non-challenged maternal endometrial (ME) 
cells 
 
The effects of OA supplementation on unchallenged ME cells are shown in Fig. 2. OA dose-
dependently increased PGE2 production at both time points compared with the CONT group 
although statistical significance was achieved in the cells supplemented with 100 µM OA at 2 
h. At 2 h the 100 µM OA also increased PGF2α production significantly whereas 
supplementation with 20 and 100 µM OA for 24 h significantly decreased PGF2α synthesis. 
The E:F ratios were increased significantly following OA supplementation at both 
concentrations and time points. 
 
Effect of OA supplementation on PG production by challenged ME cells 
 
The combined effects of challenging endometrial cells with OT, LPS or DEX in the presence 
of OA are shown in Figs 3, 4 and 5 respectively. OA did not alter the effect of OT on PG 
production at 2 h whereas at 24 h production of both PGE2 and PGF2α was significantly 
inhibited. The E:F ratios were significantly increased by OA supplementation at 2 h compared 
to the cells without OA supplementation (Fig 3).  
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In the presence of LPS, supplementation with 20 or 100 µM OA stimulated PGE2 and PGF2α 
production at 2 h and 100 µM OA increased PGE2 generation at 24 h. The E:F ratios were 
increased by OA supplementation compared with the CONT cells at both time points (Fig 4).  
 
In cells treated with DEX (Fig 5), OA did not generally alter production of either PGE2 or 
PGF2α or the E:F ratios. The only significant change was in the 100 µM OA supplementation  
group for PGF2α production at 2 h, where PGF2α concentrations were higher than the CONT 
group.  
 
Effect of OA supplementation on PGE2 production by FC cells 
 
Only PGE2 production was measured in FC cells as we have shown previously that production 
of PGF2α is negligible/undetectable [30]. FC cells were also not challenged with OT as they 
are unresponsive (data not shown). Neither LPS, DEX nor DEX + LPS given alone influenced 
PGE2 concentrations after 2 h. In contrast, LPS stimulated high production of PGE2 after 24 h 
whilst DEX not only suppressed PGE2 production at this time point but also completely 
prevented the stimulatory effect of LPS (Fig 6). OA alone caused a slight increase in PGE2 
concentrations in non-challenged FC cells, although this was only significant with 100 μM OA 
after 2 h (Fig 6a). Similar results were seen after LPS challenge (Fig 6b). In FC cells challenged 
with DEX (Fig 6c) or the combination of DEX + LPS (Fig 6d), OA supplementation did not 
significantly alter PGE2 production. 
 
Discussion 
Prostaglandins generated in the fetal placenta and maternal endometrium play crucial roles in 
fetal maturation and parturition [19, 20]. The ewe is a well-established model for studying these 
mechanisms [31, 32]. OA is a major component of NEFAs with evidence to suggest that 
concentrations of OA are elevated in women with obesity and that this may contribute to 
complications such as pre-eclampsia and premature delivery [3, 6, 9]. On the other hand, OA 
supplementation is credited with beneficial actions on neutralising the negative effects of 
dietary saturated fatty acids [14, 33]. There is, however, very little evidence available to show 
the effects of OA on PG production in tissues from the female reproductive tract.  In the present 
study we investigated the effect of OA supplementation alone on PG produced by cells isolated 
from the endometrium and fetal placenta from late gestation ewes. We also determined the 
effects of OA on a variety of factors known to regulate uterine PG production during pregnancy 
and parturition. The key findings of the study are that supplementing ME and FC cells with 
OA altered: 1) basal PG production; 2) the effects of OT, LPS and DEX on PG production and 
3) the ratio of PGE2 to PGF2α produced. 
Arachidonic acid (AA) released from the cell phospholipid membrane store is metabolized to 
PGE2 and PGF2α by the action of PTGS enzymes PTGS1 and PTGS2 [34]. PTGS1 is 
considered as a house keeping gene and is responsible for immediate responses whereas PTGS2 
is an inducible enzyme and crucial for more-sustained PG production [35]. Previous studies 
have shown that both OT and LPS stimulate A2 and PTGS2 expression and result in increased 
PG output [26, 36]. In the present study, OT challenge stimulated both PGE2 and PGF2α 
production at 2 h followed by an intensive increase at 24 h while the stimulatory effect of LPS 
was only observed at 24 h. This is in accord with our previous studies showing the presence of 
OTR in luminal epithelium of late pregnant ewes [22] so OT may not only induce PTGS2 
expression, but also cause an immediate release of PGs from the cells. LPS might act on PTGS2 
only since this inducible enzyme needs about 6 h to reach peak expression following induction 
[37]. 
6 
 
In the absence of OA, similar concentrations of PGE2 and PGF2α were synthesised by the 
endometrium and challenges with OT and LPS significantly increased PG production without 
altering the E:F ratios. OA supplementation to unchallenged ME cells caused a moderate 
increase in PGE2 production whereas it significantly decreased PGF2α production, thus altering 
the E:F ratios. OA also increased PGE2 production in the fetal placenta. Our previous work has 
similarly demonstrated that supplementation of ME cells isolated from late gestation ewes with 
LA, conjugated LA, GLA and AA also increased the E:F ratios [28, 38]. In contrast to our data, 
it was demonstrated that LPS induced an endocrine switch from PGF2α to PGE2 in bovine 
uterine endometrial cells [39]. The reasons for this difference are not clear but the previous 
study was carried out in tissue from non-pregnant cows while the endometrial cells used here 
were isolated from late gestation ewes. In the non-pregnant ewe, PGF2α is principally produced 
by epithelial cells and PGE2 by stromal cells [40]. Different cell types may have different 
capacities for fatty acid incorporation, metabolism and signalling pathways due to differences 
in enzyme systems, cellular structures and membrane receptors present, and they may use 
different AA pools for PG production.  
In endometrium both tested concentrations of OA caused a marked inhibition in the response 
to OT after 24 h, with PGE2 and PGF2α outputs reduced by about 45 and 70%, respectively. 
OA did not, however, prevent the rise in PGE2 after LPS treatment. There are a number of 
mechanisms through which OA could reduce PG synthesis. These include competition with 
AA for incorporation into the phospholipid membrane so reducing AA availability for n-6 
PUFA metabolism. OA may also compete for PTGS enzymes systems to reduce conversion of 
AA into PGs due to substrate diversity of the desaturase and PTGS isozymes [15]. This does 
not, however, explain the increased PGE2 concentrations following OA treatment in 
unchallenged ME and FC cells. It is perhaps more likely that OA supplementation disrupted 
OT signalling. Both cholesterol concentrations and localization within caveolin-1 enriched 
domains have previously been shown to alter OT signalling [41, 42]. No evidence for this was, 
however, found in a study of immortalised human myometrial cells in which there were no 
significant differences between BSA and OA treatments with respect to changes in intracellular 
Ca2+, phosphatidylinositol turnover or oxytocin binding capacity or binding affinity following 
an OT challenge [11]. Using a different approach, we have recently correlated circulating 
NEFA concentrations in postpartum cows treated to induce differing degrees of negative 
energy balance as described previously [43] with microarray gene expression data in the 
endometrium. The NEFA level was significantly associated with expression of over 1000 genes 
and activation of over 100 pathways and biological processes. Of particular relevance here 
were NFkB signalling and numerous inflammatory/immune pathways and its positive 
correlation with PTGS2 expression (r = 0.71) (Z. Cheng and D.C. Wathes, unpublished 
observations). 
In terms of physiological relevance, an increase in basal PGE2 production by OA may benefit 
fetal maturation, membrane rupture and cervical ripening [23]. However the inhibition of OT 
stimulated PG production by OA may have adverse effects on parturition and delivery as PGF2α 
synthesised by the ME induces myometrial contractions and delivery. In support of this, a 
recent epidemiological study has shown that pregnant women consuming higher levels of OA 
had increased OA concentrations and OA:n-6 PUFA ratios in their maternal and neonatal 
plasma, and were at increased risk of complications during  labour, with 50% of the women  
having caesarean section [44]. This was 31% higher than those that consumed low levels of 
OA. In contrast, preterm infants had significant lower OA in their sera, indicating insufficient 
OA transport in the maternal placenta [45]. Thus specific epidemiological studies are required 
to confirm these interesting findings.  
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In conclusion, chronic supplementation of ME and FC cells isolated from late gestation ewes 
with OA significantly changed the proportion and concentrations of PG produced and altered 
the responsiveness of these cells to challenges with OT and LPS. OA increased PGE2 
production in both ME and FC cells. OA supplementation favours basal PGE2 production to 
increase the ratios of PGE2 to PGF2α in both non-challenged and LPS treated cells, whereas it 
significantly reduced the stimulatory effect of OT on uterine PGE2 and PGF2α production. 
These results suggest that raised circulating OA or chronic OA supplementation may affect 
both the initiation and progression of parturition.  
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Figure legends 
Fig. 1. The effect of oleic acid (OA) supplementation on basal prostaglandin (PG) production 
by maternal endometrial cells isolated from late gestation ewes (day 135).  Cells were grown 
to confluence, rinsed with fatty acid free medium, cultured for 45 h in medium containing 0, 
20 or 100 µM OA, then changed with the same media and cultured for 2 and 24 h. There were 
four replicates per treatment for each ewe and 3 ewes per treatment. CONT = control medium, 
OA20 = 20 µM oleic acid, OA100 = 100 µM oleic acid.  * P<0.05 and ** P<0.01 compared 
with CONT. 
 
Fig. 2. The effect of challenge on prostaglandin (PG) production by maternal endometrial cells 
isolated from late gestation ewes (day 135). Cells were grown to confluence, rinsed with fatty 
acid free medium, cultured for 45 h in medium without OA, and then received the challenges. 
There were four replicates per treatment for each ewe and 3 ewes per treatment. Medium was 
collected at 2 and 24 h after challenge. CM = challenge free control, OT = 250 nM oxytocin, 
LPS = 0.1 µg/ml lipopolysaccharide, DEX = 5 µM dexamethasone. a>b>c>d, P<0.05-0.01.   
 
Fig. 3. The effect of oleic acid supplementation on prostaglandin (PG) production by maternal 
endometrial cells isolated from late gestation ewes (day 135) and challenged with oxytocin. 
Cells were grown to confluence, rinsed with fatty acid free medium and cultured for 45 h in 
medium containing 0, 20 or 100 µM OA. All cells were challenged with 250 nM oxytocin for 
2 and 24 h. There were four replicates per treatment for each ewe and 3 ewes per treatment. 
CONT = OA free control medium, OA20 = 20 µM oleic acid, OA100 = 100 µM oleic acid.  ** 
P<0.01 compared with CONT. 
 
Fig. 4. The effect of oleic acid supplementation on prostaglandin (PG) production by maternal 
endometrial cells isolated from late gestation ewes (day 135) and challenged with 
lipopolysaccharide (LPS). Cells were grown to confluence, rinsed with fatty acid free medium 
and cultured for 45 h in medium containing 0, 20 or 100 µM OA. All cells were challenged 
with 0.1 µM LPS for 2 and 24 h. There were four replicates per treatment for each ewe and 3 
ewes per treatment. CONT = OA free control medium, OA20 = 20 µM oleic acid, OA100 = 
100 µM oleic acid.  * P<0.05 and ** P<0.01 compared with CONT. 
 
Fig. 5. The effect of oleic acid supplementation on prostaglandin production by maternal 
endometrial cells isolated from late gestation ewes (day 135) and challenged with 
dexamethasone (DEX). Cells were grown to confluence, rinsed with fatty acid free medium 
and cultured for 45 h in medium containing 0, 20 or 100 µM OA. Then, all cells were 
challenged with 5 µM DEX for 2 and 24 h. There were four replicates per treatment for each 
ewe and 3 ewes per treatment. CONT = OA free control medium, OA20 = 20 µM oleic acid, 
OA100 = 100 µM oleic acid.  * P<0.05 compared with CONT. 
 
Fig. 6. The effect of oleic acid supplementation on prostaglandin E2 production by fetal 
allantochorion cells isolated from late gestation ewes (day 135) at absence or presence of 
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different challenges. Cells were grown to confluence, rinsed with fatty acid free medium and 
cultured for 45 h in medium containing 0 (CONT), 20 or 100 µM OA and then challenged with 
control medium (a, CM), 0.1 µg/ml lipopolysaccharide (b, LPS), 5µM dexamethasone (c, DEX) 
or 0.1 µg/LPS + 5 µM DEX (d, LPS+DEX). CONT = OA free control medium, OA20 = 20 
µM oleic acid, OA100 = 100 µM oleic acid. There were four replicates per treatment for each 
ewe and 3 ewes per treatment. Medium was collected at 2 and 24 h after challenge. * P<0.05 
and ** P<0.01 compared with CONT. 
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